Strategies for treatment-resistant depression

Clinical Cornerstone

Volumn 1, Issue 4, 1999, Pages 58-71

  Janicak, Philip G ^a   Martis, Brian ^a  

^a UNIVERSITY OF ILLINOIS AT CHICAGO   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIDEPRESSANT AGENT; BUSPIRONE; LITHIUM DERIVATIVE;

CLASSIFICATION; DEPRESSION; DRUG COMBINATION; HUMAN; MULTIMODALITY CANCER THERAPY; PSYCHIATRIC TREATMENT; REVIEW; SUICIDE;

ANTIDEPRESSIVE AGENTS; BUSPIRONE; COMBINED MODALITY THERAPY; DEPRESSIVE DISORDER; DRUG THERAPY, COMBINATION; HUMANS; LITHIUM COMPOUNDS; PSYCHIATRIC SOMATIC THERAPIES; SUICIDE;

EID: 0033252658     PISSN: 10983597     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1098-3597(99)90024-8     Document Type: Article

References (22)

1. Barraclough B, Bunch J, Nelson B, Sainsbury P. A hundred cases of suicide: clinical aspects. Br J Psychiatry. 1974;125:355-373.
2. Dorpat TL, Ripley HS. A study of suicide in the Seattle area. Compr Psychiatry. 1960;1:349-359.
3. Janicak PG, Davis JM, Preskorn SH, Ayd FA Jr. Principles and Practice of Psychopharmacotherapy. 2nd ed. Baltimore, Md: Williams & Wilkins; 1997:219-387.
4. Musselman DL, Evans DL, Nemeroff CB. The relationship of depression to cardiovascular disease: epidemiology, biology and treatment. Arch Gen Psychiatry. 1998;55:580-592.
5. Janicak PG, Davis JM, Preskorn SH, Ayd FA Jr. Principles and Practice of Psychopharmacotherapy. 2nd ed. Baltimore, Md: Williams & Wilkins; 1997:319-321.
6. Beck AT, Ward CH, Mendelson M, et al. An inventory for measuring depression. Arch Gen Psychiatry, 1961;4: 561-571.
7. Guy W, ed. ECDEU Assessment Manual for Psychopharmacology. Washington, DC: US Government Printing Office; 1976. DHEW Publication ADM 76-338.
8. Thase ME. The role of psychosocial factors and psychotherapy in refractory depression: missing pieces in the puzzle of treatment resistance? In: Nolen WA, Zohar J, Roose SP, et al, eds. Refractory Depression: Current Strategies and Future Directions. Chichester, UK: John Wiley & Sons; 1994:129-142.
9. Fava GA, Savron G, Grandi S, et al. Cognitive-behavioral management of drug-resistant major depressive disorder. J Clin Psychiatry. 1997;58:278-282.
10. Thase ME, Howland RH, Friedman ES. Treating antidepressant nonresponders with augmentation strategies: an overview. J Clin Psychiatry. 1998;59(suppl 5):5-12.
11. Rouillion F, Gorwood P. The use of lithium to augment antidepressant medication. J Clin Psychiatry. 1998;59 (suppl 5):32-39.
12. Esposito S, Prange AJ Jr, Golden RN. The thyroid axis and mood disorders: overview and future prospects. Psychopharmacol Bull. 1997;33:205-217.
13. Bauer M, Hellweg R, Graf KJ, et al. Treatment of refractory depression with high-dose thyroxine. Neuropsychopharmacology. 1998;18:444-455.
14. Joffe RT, Singer W, Levitt AJ, et al. A placebocontrolled comparison of lithium and triiodothyronine augmentation of tricyclic antidepressants in unipolar refractory depression. Arch Gen Psychiatry. 1993;50: 387-393.
15. Nelson JC. Overcoming treatment resistance in depression. J Clin Psychiatry. 1998;59(suppl 16):13-19.
16. Sussman N. Anxiolytic antidepressant augmentation. J Clin Psychiatry. 1998;59(suppl 5):42-48.
17. Blier P, Bergeron R. The use of pindolol to potentiate antidepressant medication. J Clin Psychiatry. 1998;59 (suppl 5):16-23.
18. Janicak PG, Lipnski J, Davis JM, et al. Parenteral s-adenosyl-methionine (SAMe) in depression: literature review and preliminary data. Psychopharmacol Bull. 1989;25:238-242.
19. Hornig-Rohan M, Wolkowitz O, Amsterdam JD. Novel strategies for treatment resistant depression. Psychiatr Clin North Am. 1996;19:387-405.
20. Janicak PG, Davis JM, Preskorn SH, Ayd FA Jr. Principles and Practice of Psychopharmacotherapy. 2nd ed. Baltimore, Md: Williams & Wilkins; 1997:357-387.
21. Janicak PG, Davis JM, Preskorn SH, Ayd FA Jr. Principles and Practice of Psychopharmacotherapy. 2nd ed. Baltimore, Md: Williams & Wilkins; 1997: 382-385.
22. Beedle D, Krasuski J, Janicak PG. Advances in somatic therapies: electroconvulsive therapy, repetitive transcranial magnetic stimulation and bright light therapy. In: Janicak PG, ed. Principles and Practice of Psychopharmacotherapy. 2nd ed. Update 1. Baltimore, Md: Williams & Wilkins; 1998:1-17.